Koyfin Home > Directory > Health Care > Acorda Therapeutics > Long-term Debt / Equity

Acorda Therapeutics Long-term Debt / Equity Chart (ACOR)

Acorda Therapeutics annual/quarterly Long-term Debt / Equity from 2010 to 2020.
  • Acorda Therapeutics Long-term Debt / Equity for the quarter ending June 06, 2020 was $61m a -118.54% decrease of -72m year over year
  • Acorda Therapeutics Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $61m a -118.54% decrease of -72m year over year
  • Acorda Therapeutics Annual Long-term Debt / Equity for 2019 was $78m a 27.77% increase of 22m from 2018
  • Acorda Therapeutics Annual Long-term Debt / Equity for 2018 was $56m a -14.72% decrease of -8m from 2017
  • Acorda Therapeutics Annual Long-term Debt / Equity for 2017 was $64m a 24.16% increase of 16m from 2016
Other Ratios Metrics:
  • Acorda Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $36m a -5.79% decrease of -2m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $56m a -9.35% decrease of -5m year over year
View Chart On Koyfin

Quarterly ACOR Long-term Debt / Equity Data

06/2020$61m
03/2020$79m
12/2019$78m
09/2019$133m
06/2019$69m
03/2019$66m
12/2018$56m
09/2018$57m
06/2018$56m
03/2018$61m

Annual ACOR Long-term Debt / Equity Data

2019$78m
2018$56m
2017$64m
2016$49m
2015$48m
2014$54m
2013$1m
2012$1m
2011$3m
2010$4m